Health insurance platform Bind has raised funding from a consortium featuring strategic partner UnitedHealthcare and Ascension Ventures.

The cancer therapy developer has closed an $11.1m series A round featuring M Ventures and seed-stage backer Novo Seeds.

The home products producer will use the proceeds from the Grace Beauty Capital-backed series C round to expand its range and open more stores.

The software automation platform has now raised $127m in funding in total, raising cash in a Cisco Investments-led round that included VMware.

The GV-backed cancer drug developer floated at the top of its range in an offering that could reach $129m.

Tasly Pharmaceuticals contributed to a series C round for the immunotherapy developer, a year after backing its $150m series B.

Corporate venturing unit Telstra Ventures has transferred its assets into a partnership with HarbourVest reportedly sized at $500m.

The Tencent-backed group buying platform has filed to list in the US having raised almost $2.4bn in funding over the past year.

The enterprise AI software startup increased its overall funding to $51m in a Dell Technologies Capital-led series B round.

The SoftBank-backed genetic liquid biopsy technology developer has raised a nine-figure renminbi amount in a Shenzhen Capital-led round.